Coordination meeting - National focal points for human African trypanosomiasis
Date: 10–13 March 2015
Venue: Yaoundé, Cameroon
Participants will review disease epidemiology and analyse implementation plans for 2015. Coordination of WHO support to countries will be evaluated and the implementation of an integrated surveillance system discussed.
Meeting on control of Buruli ulcerr
Date: 23–25 March 2015
Venue: Executive Board Room, WHO Headquarters, Geneva, Switzerland
The meeting will review the epidemiological situation in countries where Buruli ulcer is occurring. Around 150 participants attending this year’s meeting will share information activities relating to Buruli ulcer control, research and evaluate achievements. The meeting will also discuss current coordination of control strategy and will look at control and research priorities for the next two years.
Production of a handbook on vector surveillance and control at ports, airports and ground crossings
Date: 24–26 March 2015
Venue: WHO HQ, Room M405, Geneva, Switzerland
Participants will review contents of a handbook on vector surveillance and control at ports, airports and ground crossings. This handbook aims at assisting public health authorities at Points of Entry in strengthening core capacities and to manage vector surveillance and control programmes.
Eighth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases
Date: 21–22 April 2015 | Geneva
Venue: WHO/HQ Salle D
The STAG is the principal advisory group to WHO for the control of NTDs and reports directly to the Director-General of WHO. Its mandate is to advise WHO on overall global policies and strategies, ranging from monitoring of implementation to delivery and linkages with other health interventions.
19th Annual Meeting WHO’s Alliance for the Global Elimination of Blinding Trachoma by 2020 (GET2020)
Date: 27–29 April 2015
Venue: Hammamet, Tunisia
The meeting will discuss progress towards achieving global elimination of trachoma. Participants will also share information and experience on the implementation of the SAFE strategy and discuss obstacles and barriers towards eliminating of trachoma as a public health problem by the year 2020.